CINECA IRIS Institutional Research Information System

TRUNFIO, MATTIA GIOVANNI CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.784
EU - Europa 903
AS - Asia 458
SA - Sud America 107
AF - Africa 71
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.745
IT - Italia 334
IE - Irlanda 166
CN - Cina 151
SE - Svezia 98
VN - Vietnam 64
IN - India 55
AT - Austria 52
GB - Regno Unito 47
DE - Germania 43
FR - Francia 39
CO - Colombia 35
ES - Italia 25
BR - Brasile 23
TH - Thailandia 23
AU - Australia 22
AR - Argentina 21
SG - Singapore 21
HK - Hong Kong 20
CA - Canada 19
IR - Iran 19
ZA - Sudafrica 19
ID - Indonesia 17
NL - Olanda 17
JP - Giappone 15
MX - Messico 15
PE - Perù 15
KR - Corea 13
KE - Kenya 12
PH - Filippine 12
TW - Taiwan 12
UA - Ucraina 12
MY - Malesia 11
FI - Finlandia 10
RU - Federazione Russa 10
GR - Grecia 9
NG - Nigeria 8
TZ - Tanzania 8
PL - Polonia 6
PT - Portogallo 6
SA - Arabia Saudita 6
BE - Belgio 5
CL - Cile 5
DZ - Algeria 5
IL - Israele 5
PY - Paraguay 5
HU - Ungheria 4
MW - Malawi 4
PK - Pakistan 4
TR - Turchia 4
CH - Svizzera 3
CR - Costa Rica 3
EG - Egitto 3
NO - Norvegia 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CD - Congo 2
CZ - Repubblica Ceca 2
GH - Ghana 2
LV - Lettonia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
SD - Sudan 1
UY - Uruguay 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 3.347
Salva come PNG Salva come JPEG
Città #
Chandler 374
Dublin 166
Fairfield 113
Ashburn 90
Torino 82
Redwood City 80
Turin 71
Nyköping 67
Medford 61
Beijing 50
Wilmington 50
Woodbridge 50
Princeton 45
Cambridge 38
Houston 35
Ann Arbor 33
Jacksonville 29
San Diego 28
Seattle 27
Milan 23
Hangzhou 22
New York 21
Hebei 19
Dong Ket 16
Dearborn 13
Seoul 13
Washington 13
Singapore 12
Lima 11
Buenos Aires 10
London 10
Melbourne 10
Vienna 10
Grugliasco 9
Ho Chi Minh City 9
Paris 9
São Paulo 9
Upper Marlboro 9
Bangkok 8
Medellín 8
Mumbai 8
Pisa 8
Villeurbanne 8
Chengdu 7
Duncan 7
Falls Church 7
Frankfurt am Main 7
Guiyang 7
Jakarta 7
Johannesburg 7
Kuala Lumpur 7
Los Angeles 7
Norwalk 7
Raleigh 7
Riverton 7
Yekaterinburg 7
Abuja 6
Cartagena 6
Central 6
Chandigarh 6
Fredericton 6
Genoa 6
Hefei 6
Hong Kong 6
Ottawa 6
Algiers 5
Chicago 5
Guangzhou 5
Gurgaon 5
Helsinki 5
Nanterre 5
Pune 5
Richmond 5
Sydney 5
Tainan City 5
Barcelona 4
Barranquilla 4
Bengaluru 4
Boston 4
Brussels 4
Buffalo 4
Cape Town 4
Central District 4
Cinisello Balsamo 4
Collegno 4
Dar es Salaam 4
Dodoma 4
La Plata 4
Minneapolis 4
Modena 4
Nanjing 4
Rome 4
Santiago 4
Sävedalen 4
Udine 4
Warsaw 4
Athens 3
Berlin 3
Bogotá 3
Bolano 3
Totale 2.068
Salva come PNG Salva come JPEG
Nome #
Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern 321
CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose 242
Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid 207
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia 141
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV 128
Cognitive Neuro-Rehabilitation of HIV-Associated Neurocognitive Disorders: Case Reports of A New Computer-Based Restorative Approach In 3 Hiv-Positive Cart-Treated Patients 122
The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series 120
Medication Burden and Clustering in People Living with HIV Undergoing Therapeutic Drug Monitoring 119
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy 111
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? 107
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections 105
Cerebrospinal Fluid viral load across the spectrum of untreated HIV-1 infection: a cross-sectional multi-center study 86
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection 68
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity 66
Co-infection with other respiratory pathogens in COVID-19 patients 66
Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy 63
Ultrasonography of an oral cavity onchocercidae nodule 61
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders 60
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients 59
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes 56
Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers 52
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 50
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient 49
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases 48
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 48
The manifesto of pharmacoenosis: Merging hiv pharmacology into pathocoenosis and syndemics in developing countries 46
Alzheimer Dementia in People Living With HIV 46
HIV-1 detection in the olfactory mucosa of HIV-1 infected participants 44
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases 44
JC virus DNA in cerebrospinal fluid: insight into clinical significance 42
Clinical and VIRO-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients 41
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis 39
Clinical phenotype and contagiousness of early breakthrough SARS-CoV-2 infections after BNT162b2 COVID-19 mRNA vaccine: A parallel cohort study in healthcare workers 38
Dupilumab in HIV-positive patients with atopic dermatitis: A long-term follow-up patient and a literature review 38
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders 35
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy 33
Screening Accuracy of Mini Addenbrooke’s Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV 33
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs 30
The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? 28
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV 28
Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition 27
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases 26
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy 24
Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART) 23
Malignant melanoma in people living with HIV/AIDS: Can we know more, can we do better? 22
Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV 20
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system? 20
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study 19
Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options 18
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia 18
The role of antirheumatics in patients with COVID-19 18
Norepinephrine may improve survival of septic shock patients in a low-resource setting: a proof-of-concept study on feasibility and efficacy outside the Intensive Care Unit 17
COVID-19: A Possible Contribution of the MAPK Pathway 15
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants 15
Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lata 14
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood-brain barrier, beta amyloid, and tau proteins in people living with HIV 12
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV 6
Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs 4
Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review 4
Use of different anticholinergic scales and their correlation with anticholinergic symptom burden in a cohort of people living with HIV 4
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen 3
Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV 3
Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV 2
Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV 2
Intrathecal production of anti-EBV Viral Capsid Antigen IgG is associated with Neurocognition and tau pathology in people with HIV 2
Use of self-prescribed medications and complementary medicines in a cohort of women with HIV 2
Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA 2
Living with HIV and Getting Vaccinated: A Narrative Review 2
Risk of hospitalization and sequelae in patients with COVID‐19 treated with 3‐day early remdesivir vs. controls in the vaccine and Omicron era: A real‐life cohort study 2
Cognitive criteria in HIV: greater consensus is needed 2
Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis 2
The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis 2
Totale 3.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 0 18 4
2019/2020225 2 2 3 19 7 19 24 21 25 23 30 50
2020/2021419 20 22 37 18 39 22 32 12 16 67 50 84
2021/2022787 58 50 35 42 61 70 42 51 22 77 121 158
2022/20231.200 93 123 51 123 98 268 73 95 97 39 81 59
2023/2024701 94 113 47 47 63 116 57 56 22 76 10 0
Totale 3.472